Clarithromycin, Midazolam, and Digoxin: Application of PBPK Modeling to Gain New Insights into Drug–Drug Interactions and Co-medication Regimens
Crossref DOI link: https://doi.org/10.1208/s12248-016-0009-9
Published Online: 2016-11-07
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Moj, Daniel
Hanke, Nina
Britz, Hannah
Frechen, Sebastian
Kanacher, Tobias
Wendl, Thomas
Haefeli, Walter Emil
Lehr, Thorsten
License valid from 2016-11-07